Piu Medical SpAMIL:PMED 13 Return-on-Tangible-Equity is Negative Tangible Equity% as of Jun. 2025. GuruFocus rates MIL:PMED with a GF Score™ of 13/100. The stock has 4 warning signs investors should review. Among 582 Healthcare Providers & Services companies, Piu Medical SpA ranks worse than 81.96% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Piu Medical SpA's annualized net income for the quarter that ended in Jun. 2025 was €0.14 Mil. Piu Medical SpA's average shareholder tangible equity for the quarter that ended in Jun. 2025 was €-4.50 Mil. Therefore, Piu Medical SpA's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2025 was Negative Tangible Equity%.
The historical rank and industry rank for Piu Medical SpA's Return-on-Tangible-Equity or its related term are showing as below:
MIL:PMED'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -11.31 Med: -1.42 Max: -1.42
Current: -11.31
During the past 3 years, Piu Medical SpA's highest Return-on-Tangible-Equity was -1.42%. The lowest was -11.31%. And the median was -1.42%.
MIL:PMED's Return-on-Tangible-Equity is ranked worse than 81.96% of 582
companies
in the Healthcare Providers & Services industry
Industry Median: 9.965
vs MIL:PMED: -11.31
Piu Medical SpA (MIL:PMED) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Piu Medical SpA Return-on-Tangible-Equity Related Terms
Piu Medical SpA Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Piu Medical SpA's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Piu Medical SpA Return-on-Tangible-Equity Chart
Piu Medical SpA Annual Data
Trend
Dec23
Dec24
Dec25
Return-on-Tangible-Equity
Negative Tangible Equity
Negative Tangible Equity
-1.42
Piu Medical SpA Semi-Annual Data
Dec23
Dec24
Jun25
Dec25
Return-on-Tangible-Equity
0.00
0.00
Negative Tangible Equity
-8.08
Piu Medical SpA Return-on-Tangible-Equity Competitor Comparison
For the Pharmaceutical Retailers subindustry, Piu Medical SpA's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Piu Medical SpA Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Piu Medical SpA's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Piu Medical SpA's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Jun. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of Negative Tangible Equity% mean?
Piu Medical SpA (MIL:PMED) has a Return-on-Tangible-Equity of Negative Tangible Equity% as of Jun. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Piu Medical SpA and its competitors. According to the industry distribution chart, Piu Medical SpA ranks #477 out of 582 companies in the Healthcare Providers & Services industry, placing it in the top 82%.
Is Piu Medical SpA's Return-on-Tangible-Equity too high?
Piu Medical SpA's current Return-on-Tangible-Equity is Negative Tangible Equity%. Based on the distribution chart, Piu Medical SpA ranks #477 out of 582 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Piu Medical SpA has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Piu Medical SpA's Return-on-Tangible-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Piu Medical SpA ranks #477 out of 582 companies for Return-on-Tangible-Equity. This places Piu Medical SpA in the lower half of its industry. The industry median Return-on-Tangible-Equity is 9.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 9.97, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Piu Medical SpA and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 9.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Piu Medical SpA's current Return-on-Tangible-Equity is Negative Tangible Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Piu Medical SpA stock overvalued right now?
Piu Medical SpA (MIL:PMED) has a current Return-on-Tangible-Equity of Negative Tangible Equity%. The current Return-on-Tangible-Equity is Negative Tangible Equity%. Piu Medical SpA's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Piu Medical SpA (MIL:PMED), the current Return-on-Tangible-Equity is Negative Tangible Equity% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Piu Medical SpA specializes in the retail distribution of pharmaceutical and parapharmaceutical products. Its activity includes: sale of prescription drugs; sale of OTC and parapharmaceutical products: OTC medicines, dietary supplements, medical devices, paramedical products, personal care and wellness products, homeopathic medicines, cosmetics, etc.; services: diagnostic testing services, blood parameter analysis and control (glycemia, cholesterol, triglycerides, etc.), rapid testing and screening, nutritional consultation, remote medical assistance and monitoring, telemedicine, etc.
13GF Score
Get the complete analysis for MIL:PMED
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PMED has been successfully added to your 